Загрузка...
Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
BACKGROUND: Smoking is one of well known environmental factors causing endothelial dysfunction and plays important role in the atherosclerosis. We investigated the effect of cilostazol could improve the endothelial dysfunction in smokers with the measurement of flow-mediated dilatation (FMD). METHOD...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Society of Echocardiography
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3079080/ https://ncbi.nlm.nih.gov/pubmed/21519488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4250/jcu.2011.19.1.21 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|